Solid Biosciences (SLDB) Share-based Compensation (2017 - 2024)
Historic Share-based Compensation for Solid Biosciences (SLDB) over the last 8 years, with Q4 2024 value amounting to $3.8 million.
- Solid Biosciences' Share-based Compensation rose 9716.2% to $3.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $10.5 million, marking a year-over-year increase of 3795.41%. This contributed to the annual value of $10.5 million for FY2024, which is 3795.41% up from last year.
- As of Q4 2024, Solid Biosciences' Share-based Compensation stood at $3.8 million, which was up 9716.2% from $3.0 million recorded in Q3 2024.
- Solid Biosciences' 5-year Share-based Compensation high stood at $3.8 million for Q4 2024, and its period low was $1.5 million during Q3 2022.
- Its 5-year average for Share-based Compensation is $2.5 million, with a median of $2.6 million in 2020.
- In the last 5 years, Solid Biosciences' Share-based Compensation tumbled by 5538.64% in 2022 and then soared by 9716.2% in 2024.
- Solid Biosciences' Share-based Compensation (Quarter) stood at $2.5 million in 2020, then soared by 35.62% to $3.4 million in 2021, then tumbled by 53.53% to $1.6 million in 2022, then rose by 22.12% to $1.9 million in 2023, then skyrocketed by 97.16% to $3.8 million in 2024.
- Its last three reported values are $3.8 million in Q4 2024, $3.0 million for Q3 2024, and $2.1 million during Q2 2024.